Anderson Hoagland & Co’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.18M | Sell |
9,834
-63
| -0.6% | -$35.3K | 0.41% | 62 |
|
|
2026
Q1 | $5.56M | Hold |
9,897
| – | – | 0.48% | 56 |
|
|
2025
Q4 | $6.7M | Hold |
9,897
| – | – | 0.58% | 49 |
|
|
2025
Q3 | $6.32M | Sell |
9,897
-28
| -0.3% | -$17K | 0.57% | 48 |
|
|
2025
Q2 | $5.32M | Buy |
9,925
+17
| +0.2% | +$8.13K | 0.51% | 52 |
|
|
2025
Q1 | $3.58M | Hold |
9,908
| – | – | 0.42% | 58 |
|
|
2024
Q4 | $4.15M | Hold |
9,908
| – | – | 0.43% | 58 |
|
|
2024
Q3 | $4.73M | Sell |
9,908
-613
| -6% | -$298K | 0.48% | 50 |
|
|
2024
Q2 | $5.03M | Hold |
10,521
| – | – | 0.53% | 51 |
|
|
2024
Q1 | $5.3M | Sell |
10,521
-644
| -6% | -$352K | 0.59% | 48 |
|
|
2023
Q4 | $5.81M | Hold |
11,165
| – | – | 0.71% | 42 |
|
|
2023
Q3 | $4.88M | Buy |
11,165
+2
| +0% | +$997 | 0.65% | 38 |
|
|
2023
Q2 | $5.61M | Hold |
11,163
| – | – | 0.72% | 33 |
|
|
2023
Q1 | $5.58M | Hold |
11,163
| – | – | 0.8% | 35 |
|
|
2022
Q4 | $5.3M | Hold |
11,163
| – | – | 0.77% | 39 |
|
|
2022
Q3 | $3.64M | Buy |
11,163
+31
| +0.3% | +$11.4K | 0.58% | 45 |
|
|
2022
Q2 | $4.26M | Hold |
11,132
| – | – | 0.64% | 43 |
|
|
2022
Q1 | $6.09M | Sell |
11,132
-83
| -0.7% | -$43.7K | 0.78% | 37 |
|
|
2021
Q4 | $5.74M | Buy |
11,215
+290
| +3% | +$182K | 0.75% | 39 |
|
|
2021
Q3 | $6.79M | Sell |
10,925
-114
| -1% | -$76.6K | 0.87% | 30 |
|
|
2021
Q2 | $6.97M | Buy |
11,039
+134
| +1% | +$74K | 0.89% | 32 |
|
|
2021
Q1 | $5.34M | Buy |
10,905
+724
| +7% | +$363K | 0.75% | 40 |
|
|
2020
Q4 | $5.09M | Buy |
10,181
+3,515
| +53% | +$1.57M | 0.81% | 37 |
|
|
2020
Q3 | $2.2M | Sell |
6,666
-185
| -3% | -$68.4K | 1.05% | 26 |
|
|
2020
Q2 | $2.26M | Buy |
6,851
+59
| +0.9% | +$17.1K | 1.07% | 26 |
|
|
2020
Q1 | $1.46M | Buy |
6,792
+2,417
| +55% | +$631K | 0.9% | 30 |
|
|
2019
Q4 | $1.1M | Hold |
4,375
| – | – | 0.62% | 50 |
|
|
2019
Q3 | $1.27M | Hold |
4,375
| – | – | 0.77% | 36 |
|
|
2019
Q2 | $1.09M | Hold |
4,375
| – | – | 0.68% | 44 |
|
|
2019
Q1 | $947K | Hold |
4,375
| – | – | 0.57% | 56 |
|
|
2018
Q4 | $810K | Hold |
4,375
| – | – | 0.57% | 59 |
|
|
2018
Q3 | $1.1M | Hold |
4,375
| – | – | 0.62% | 55 |
|
|
2018
Q2 | $953K | Hold |
4,375
| – | – | 0.53% | 65 |
|
|
2018
Q1 | $837K | Hold |
4,375
| – | – | 0.48% | 65 |
|
|
2017
Q4 | $684K | Hold |
4,375
| – | – | 0.4% | 76 |
|
|
2017
Q3 | $680K | Hold |
4,375
| – | – | 0.42% | 77 |
|
|
2017
Q2 | $706K | Hold |
4,375
| – | – | 0.45% | 70 |
|
|
2017
Q1 | $676K | Hold |
4,375
| – | – | 0.36% | 89 |
|
|
2016
Q4 | $513K | Buy |
+4,375
| New | +$499K | 0.3% | 89 |
|
Other funds holding IDXX
Anderson Hoagland & Co's IDXX Position: Q2 2026 in Review
Anderson Hoagland & Co reduced its Idexx Laboratories (IDXX) stake by 0.64% in Q2 2026, selling an estimated $35.3K and leaving 9,834 shares worth $5.18M. The position accounts for 0.41% of the portfolio, ranked #62.
Anderson Hoagland & Co first reported a position in IDXX in Q4 2016 and has held it in 39 quarters since. The position peaked at $6.97M in Q2 2021. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Anderson Hoagland & Co held 9,834 shares of Idexx Laboratories worth $5.18M as of Q2 2026.
- Anderson Hoagland & Co sold 63 Idexx Laboratories shares in Q2 2026, an estimated $35.3K.
- Idexx Laboratories made up 0.41% of Anderson Hoagland & Co's portfolio in Q2 2026, its #62 holding.
- Anderson Hoagland & Co first reported a position in Idexx Laboratories in Q4 2016 and has held it in 39 quarters since.
- Anderson Hoagland & Co's Idexx Laboratories position peaked at $6.97M in Q2 2021.
- 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Anderson Hoagland & Co's 13F filing for Q2 2026, filed 6 Jul 2026.